HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of $99.72 billion. The enterprise value is $145.04 billion.
| Market Cap | 99.72B |
| Enterprise Value | 145.04B |
Important Dates
The next confirmed earnings date is Friday, October 24, 2025, before market open.
| Earnings Date | Oct 24, 2025 |
| Ex-Dividend Date | Sep 16, 2025 |
Share Statistics
HCA Healthcare has 233.99 million shares outstanding. The number of shares has decreased by -6.69% in one year.
| Current Share Class | 233.99M |
| Shares Outstanding | 233.99M |
| Shares Change (YoY) | -6.69% |
| Shares Change (QoQ) | -3.02% |
| Owned by Insiders (%) | 1.13% |
| Owned by Institutions (%) | 65.46% |
| Float | 162.19M |
Valuation Ratios
The trailing PE ratio is 17.96 and the forward PE ratio is 15.56. HCA Healthcare's PEG ratio is 1.22.
| PE Ratio | 17.96 |
| Forward PE | 15.56 |
| PS Ratio | 1.46 |
| Forward PS | 1.29 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 13.68 |
| P/OCF Ratio | 8.36 |
| PEG Ratio | 1.22 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.00, with an EV/FCF ratio of 19.89.
| EV / Earnings | 24.29 |
| EV / Sales | 2.00 |
| EV / EBITDA | 10.00 |
| EV / EBIT | 13.09 |
| EV / FCF | 19.89 |
Financial Position
The company has a current ratio of 0.98
| Current Ratio | 0.98 |
| Quick Ratio | 0.72 |
| Debt / Equity | n/a |
| Debt / EBITDA | 2.98 |
| Debt / FCF | 6.36 |
| Interest Coverage | 5.13 |
Financial Efficiency
Return on equity (ROE) is 13,631.68% and return on invested capital (ROIC) is 15.52%.
| Return on Equity (ROE) | 13,631.68% |
| Return on Assets (ROA) | 11.84% |
| Return on Invested Capital (ROIC) | 15.52% |
| Return on Capital Employed (ROCE) | 25.41% |
| Revenue Per Employee | $230,057 |
| Profits Per Employee | $18,896 |
| Employee Count | 316,000 |
| Asset Turnover | 1.24 |
| Inventory Turnover | 23.93 |
Taxes
In the past 12 months, HCA Healthcare has paid $1.90 billion in taxes.
| Income Tax | 1.90B |
| Effective Tax Rate | 21.60% |
Stock Price Statistics
The stock price has increased by +4.14% in the last 52 weeks. The beta is 1.41, so HCA Healthcare's price volatility has been higher than the market average.
| Beta (5Y) | 1.41 |
| 52-Week Price Change | +4.14% |
| 50-Day Moving Average | 409.61 |
| 200-Day Moving Average | 361.27 |
| Relative Strength Index (RSI) | 58.69 |
| Average Volume (20 Days) | 1,140,996 |
Short Selling Information
The latest short interest is 3.56 million, so 1.52% of the outstanding shares have been sold short.
| Short Interest | 3.56M |
| Short Previous Month | 4.27M |
| Short % of Shares Out | 1.52% |
| Short % of Float | 2.20% |
| Short Ratio (days to cover) | 2.74 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of $72.70 billion and earned $5.97 billion in profits. Earnings per share was $23.73.
| Revenue | 72.70B |
| Gross Profit | 29.73B |
| Operating Income | 11.08B |
| Pretax Income | 8.78B |
| Net Income | 5.97B |
| EBITDA | 14.50B |
| EBIT | 11.08B |
| Earnings Per Share (EPS) | $23.73 |
Balance Sheet
The company has $1.04 billion in cash and $46.36 billion in debt, giving a net cash position of -$45.32 billion or -$193.70 per share.
| Cash & Cash Equivalents | 1.04B |
| Total Debt | 46.36B |
| Net Cash | -45.32B |
| Net Cash Per Share | -$193.70 |
| Equity (Book Value) | -1.24B |
| Book Value Per Share | -18.61 |
| Working Capital | -376.00M |
Cash Flow
In the last 12 months, operating cash flow was $11.94 billion and capital expenditures -$4.64 billion, giving a free cash flow of $7.29 billion.
| Operating Cash Flow | 11.94B |
| Capital Expenditures | -4.64B |
| Free Cash Flow | 7.29B |
| FCF Per Share | $31.16 |
Margins
Gross margin is 40.89%, with operating and profit margins of 15.24% and 8.21%.
| Gross Margin | 40.89% |
| Operating Margin | 15.24% |
| Pretax Margin | 12.08% |
| Profit Margin | 8.21% |
| EBITDA Margin | 19.94% |
| EBIT Margin | 15.24% |
| FCF Margin | 10.03% |
Dividends & Yields
This stock pays an annual dividend of $2.88, which amounts to a dividend yield of 0.68%.
| Dividend Per Share | $2.88 |
| Dividend Yield | 0.68% |
| Dividend Growth (YoY) | 9.30% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 11.88% |
| Buyback Yield | 6.69% |
| Shareholder Yield | 7.36% |
| Earnings Yield | 5.99% |
| FCF Yield | 7.31% |
Analyst Forecast
The average price target for HCA Healthcare is $425.00, which is -0.27% lower than the current price. The consensus rating is "Buy".
| Price Target | $425.00 |
| Price Target Difference | -0.27% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 5.83% |
| EPS Growth Forecast (5Y) | 13.24% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCA Healthcare has an Altman Z-Score of 2.6 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.6 |
| Piotroski F-Score | 6 |